T-Cell Subsets: On the Immunity Warpath

5-Prime | T-Cell Subsets: On the Immunity Warpath How do T cells recognize their targets? The acquired immune system consists of two major cell types, T and B cells, which recognize specific antigens. They differentiate from hematopoietic precursors and from each other in the bone marrow, with T cells migrating off to mature in the thymus (hence the name). The T cell is endowed with receptors (TCRs) of unique specificity, created by somatic DNA rearrangement and random chain pairing. In the

Written byJosh Roberts
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

How do T cells recognize their targets? The acquired immune system consists of two major cell types, T and B cells, which recognize specific antigens. They differentiate from hematopoietic precursors and from each other in the bone marrow, with T cells migrating off to mature in the thymus (hence the name). The T cell is endowed with receptors (TCRs) of unique specificity, created by somatic DNA rearrangement and random chain pairing. In the thymus, T cells are selected for their ability to recognize MHC (major histocompatibility complex) class I or II molecules; those with too strong an affinity for self-derived peptides are deleted from the repertoire.

Where do T cells do their work? From the thymus, T cells migrate to secondary lymphoid organs such as the spleen, lymph nodes, Peyer's patches, and tonsils. There they are "primed" by antigen-presenting cells (APCs), which display the appropriate peptide-MHC complex.

What are the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies